Aparito is a med-tech company specialising in capturing patient generated data and developing digital endpoints remotely, with an expertise in decentralised / hybrid studies. We provide innovative, patient-centric drug development solutions, integrating specialist clinical and regulatory knowledge with the technology to gather highly relevant patient-generated data outside of the hospital setting, to streamline the drug development process. Aparito is transforming healthcare by unlocking real world patient data through innovative technology.
Elin Haf Davies PhD
Chief Executive Officer
Apartio
Other speakers in 2020
Prof. Radka Kaneva, PhD
Executive Manager of Molecular Medicine Center at Medical University of Sofia
Member of BAPEMED Executive Board